nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Hepatic necrosis—Lovastatin—atherosclerosis	0.0152	0.0268	CcSEcCtD
Carboprost Tromethamine—Hepatic necrosis—Simvastatin—atherosclerosis	0.0142	0.0251	CcSEcCtD
Carboprost Tromethamine—Hepatic necrosis—Pravastatin—atherosclerosis	0.0129	0.0227	CcSEcCtD
Carboprost Tromethamine—Hyperventilation—Niacin—atherosclerosis	0.011	0.0195	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Rosuvastatin—atherosclerosis	0.00875	0.0154	CcSEcCtD
Carboprost Tromethamine—Muscle twitching—Niacin—atherosclerosis	0.00774	0.0136	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Niacin—atherosclerosis	0.00698	0.0123	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Simvastatin—atherosclerosis	0.00694	0.0122	CcSEcCtD
Carboprost Tromethamine—Hot flush—Ezetimibe—atherosclerosis	0.00673	0.0119	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00668	0.0118	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Pravastatin—atherosclerosis	0.00627	0.0111	CcSEcCtD
Carboprost Tromethamine—Hot flush—Pravastatin—atherosclerosis	0.00581	0.0102	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Pravastatin—atherosclerosis	0.00576	0.0101	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00568	0.01	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00506	0.00892	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00483	0.00851	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Lovastatin—atherosclerosis	0.00481	0.00848	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Pravastatin—atherosclerosis	0.00457	0.00806	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00436	0.00769	CcSEcCtD
Carboprost Tromethamine—Angioedema—Rosuvastatin—atherosclerosis	0.00417	0.00735	CcSEcCtD
Carboprost Tromethamine—Flushing—Lovastatin—atherosclerosis	0.00412	0.00727	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Pravastatin—atherosclerosis	0.00407	0.00717	CcSEcCtD
Carboprost Tromethamine—Flushing—Ezetimibe—atherosclerosis	0.00404	0.00713	CcSEcCtD
Carboprost Tromethamine—Chills—Lovastatin—atherosclerosis	0.00399	0.00703	CcSEcCtD
Carboprost Tromethamine—Cough—Rosuvastatin—atherosclerosis	0.00398	0.00702	CcSEcCtD
Carboprost Tromethamine—Myalgia—Rosuvastatin—atherosclerosis	0.00389	0.00685	CcSEcCtD
Carboprost Tromethamine—Flushing—Simvastatin—atherosclerosis	0.00386	0.0068	CcSEcCtD
Carboprost Tromethamine—Back pain—Lovastatin—atherosclerosis	0.00374	0.0066	CcSEcCtD
Carboprost Tromethamine—Chills—Simvastatin—atherosclerosis	0.00373	0.00657	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Lovastatin—atherosclerosis	0.00372	0.00656	CcSEcCtD
Carboprost Tromethamine—Infection—Rosuvastatin—atherosclerosis	0.0037	0.00652	CcSEcCtD
Carboprost Tromethamine—Back pain—Ezetimibe—atherosclerosis	0.00367	0.00647	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Ezetimibe—atherosclerosis	0.00365	0.00643	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Lovastatin—atherosclerosis	0.00364	0.00643	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Niacin—atherosclerosis	0.00356	0.00627	CcSEcCtD
Carboprost Tromethamine—Flushing—Niacin—atherosclerosis	0.00354	0.00624	CcSEcCtD
Carboprost Tromethamine—Angioedema—Lovastatin—atherosclerosis	0.00353	0.00623	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Pravastatin—atherosclerosis	0.0035	0.00618	CcSEcCtD
Carboprost Tromethamine—Flushing—Pravastatin—atherosclerosis	0.00349	0.00615	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Simvastatin—atherosclerosis	0.00348	0.00613	CcSEcCtD
Carboprost Tromethamine—Vertigo—Lovastatin—atherosclerosis	0.00347	0.00613	CcSEcCtD
Carboprost Tromethamine—Angioedema—Ezetimibe—atherosclerosis	0.00347	0.00611	CcSEcCtD
Carboprost Tromethamine—Chills—Niacin—atherosclerosis	0.00342	0.00604	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Simvastatin—atherosclerosis	0.00341	0.00601	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00339	0.00598	CcSEcCtD
Carboprost Tromethamine—Chills—Pravastatin—atherosclerosis	0.00337	0.00594	CcSEcCtD
Carboprost Tromethamine—Palpitations—Ezetimibe—atherosclerosis	0.00335	0.00591	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00334	0.0059	CcSEcCtD
Carboprost Tromethamine—Cough—Ezetimibe—atherosclerosis	0.00331	0.00584	CcSEcCtD
Carboprost Tromethamine—Angioedema—Simvastatin—atherosclerosis	0.00331	0.00583	CcSEcCtD
Carboprost Tromethamine—Chest pain—Lovastatin—atherosclerosis	0.00329	0.00581	CcSEcCtD
Carboprost Tromethamine—Myalgia—Lovastatin—atherosclerosis	0.00329	0.00581	CcSEcCtD
Carboprost Tromethamine—Anxiety—Lovastatin—atherosclerosis	0.00328	0.00579	CcSEcCtD
Carboprost Tromethamine—Hypertension—Ezetimibe—atherosclerosis	0.00327	0.00577	CcSEcCtD
Carboprost Tromethamine—Tension—Niacin—atherosclerosis	0.00326	0.00575	CcSEcCtD
Carboprost Tromethamine—Vertigo—Simvastatin—atherosclerosis	0.00325	0.00573	CcSEcCtD
Carboprost Tromethamine—Chest pain—Ezetimibe—atherosclerosis	0.00323	0.00569	CcSEcCtD
Carboprost Tromethamine—Myalgia—Ezetimibe—atherosclerosis	0.00323	0.00569	CcSEcCtD
Carboprost Tromethamine—Nervousness—Niacin—atherosclerosis	0.00323	0.00569	CcSEcCtD
Carboprost Tromethamine—Tension—Pravastatin—atherosclerosis	0.00321	0.00566	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Niacin—atherosclerosis	0.00319	0.00563	CcSEcCtD
Carboprost Tromethamine—Pain—Rosuvastatin—atherosclerosis	0.00318	0.00562	CcSEcCtD
Carboprost Tromethamine—Nervousness—Pravastatin—atherosclerosis	0.00318	0.0056	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00316	0.00557	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Pravastatin—atherosclerosis	0.00314	0.00554	CcSEcCtD
Carboprost Tromethamine—Infection—Lovastatin—atherosclerosis	0.00314	0.00553	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Niacin—atherosclerosis	0.00313	0.00552	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.0031	0.00546	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Pravastatin—atherosclerosis	0.00308	0.00543	CcSEcCtD
Carboprost Tromethamine—Myalgia—Simvastatin—atherosclerosis	0.00308	0.00543	CcSEcCtD
Carboprost Tromethamine—Chest pain—Simvastatin—atherosclerosis	0.00308	0.00543	CcSEcCtD
Carboprost Tromethamine—Infection—Ezetimibe—atherosclerosis	0.00308	0.00542	CcSEcCtD
Carboprost Tromethamine—Anxiety—Simvastatin—atherosclerosis	0.00307	0.00541	CcSEcCtD
Carboprost Tromethamine—Angioedema—Niacin—atherosclerosis	0.00304	0.00535	CcSEcCtD
Carboprost Tromethamine—Angioedema—Pravastatin—atherosclerosis	0.00299	0.00527	CcSEcCtD
Carboprost Tromethamine—Vertigo—Niacin—atherosclerosis	0.00298	0.00526	CcSEcCtD
Carboprost Tromethamine—Syncope—Niacin—atherosclerosis	0.00298	0.00525	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00295	0.00521	CcSEcCtD
Carboprost Tromethamine—Vertigo—Pravastatin—atherosclerosis	0.00294	0.00518	CcSEcCtD
Carboprost Tromethamine—Palpitations—Niacin—atherosclerosis	0.00294	0.00518	CcSEcCtD
Carboprost Tromethamine—Infection—Simvastatin—atherosclerosis	0.00293	0.00517	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Niacin—atherosclerosis	0.00292	0.00515	CcSEcCtD
Carboprost Tromethamine—Cough—Niacin—atherosclerosis	0.0029	0.00511	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00288	0.00507	CcSEcCtD
Carboprost Tromethamine—Cough—Pravastatin—atherosclerosis	0.00285	0.00503	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Lovastatin—atherosclerosis	0.00283	0.005	CcSEcCtD
Carboprost Tromethamine—Myalgia—Niacin—atherosclerosis	0.00283	0.00499	CcSEcCtD
Carboprost Tromethamine—Hypertension—Pravastatin—atherosclerosis	0.00282	0.00498	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00282	0.00497	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Lovastatin—atherosclerosis	0.00281	0.00496	CcSEcCtD
Carboprost Tromethamine—Chest pain—Pravastatin—atherosclerosis	0.00278	0.00491	CcSEcCtD
Carboprost Tromethamine—Myalgia—Pravastatin—atherosclerosis	0.00278	0.00491	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Ezetimibe—atherosclerosis	0.00278	0.0049	CcSEcCtD
Carboprost Tromethamine—Anxiety—Pravastatin—atherosclerosis	0.00277	0.00489	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Ezetimibe—atherosclerosis	0.00276	0.00487	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00274	0.00484	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Niacin—atherosclerosis	0.00271	0.00478	CcSEcCtD
Carboprost Tromethamine—Pain—Lovastatin—atherosclerosis	0.0027	0.00476	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00269	0.00474	CcSEcCtD
Carboprost Tromethamine—Asthenia—Rosuvastatin—atherosclerosis	0.00267	0.00471	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00267	0.00471	CcSEcCtD
Carboprost Tromethamine—Shock—Niacin—atherosclerosis	0.00267	0.0047	CcSEcCtD
Carboprost Tromethamine—Infection—Pravastatin—atherosclerosis	0.00265	0.00468	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Simvastatin—atherosclerosis	0.00265	0.00467	CcSEcCtD
Carboprost Tromethamine—Pain—Ezetimibe—atherosclerosis	0.00265	0.00467	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Niacin—atherosclerosis	0.00265	0.00467	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Simvastatin—atherosclerosis	0.00263	0.00464	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Niacin—atherosclerosis	0.00262	0.00462	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00258	0.00455	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00255	0.00449	CcSEcCtD
Carboprost Tromethamine—Pain—Simvastatin—atherosclerosis	0.00252	0.00445	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Lovastatin—atherosclerosis	0.0025	0.0044	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00247	0.00435	CcSEcCtD
Carboprost Tromethamine—Dizziness—Rosuvastatin—atherosclerosis	0.00246	0.00434	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Ezetimibe—atherosclerosis	0.00245	0.00432	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Niacin—atherosclerosis	0.00243	0.00429	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00243	0.00429	CcSEcCtD
Carboprost Tromethamine—Tafluprost—PTGS2—atherosclerosis	0.00243	1	CrCbGaD
Carboprost Tromethamine—Dyspnoea—Niacin—atherosclerosis	0.00242	0.00426	CcSEcCtD
Carboprost Tromethamine—Somnolence—Niacin—atherosclerosis	0.00241	0.00425	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Pravastatin—atherosclerosis	0.0024	0.00423	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Pravastatin—atherosclerosis	0.00238	0.0042	CcSEcCtD
Carboprost Tromethamine—Rash—Rosuvastatin—atherosclerosis	0.00235	0.00414	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Rosuvastatin—atherosclerosis	0.00235	0.00414	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Simvastatin—atherosclerosis	0.00233	0.00412	CcSEcCtD
Carboprost Tromethamine—Headache—Rosuvastatin—atherosclerosis	0.00233	0.00411	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Lovastatin—atherosclerosis	0.00233	0.0041	CcSEcCtD
Carboprost Tromethamine—Pain—Niacin—atherosclerosis	0.00232	0.00409	CcSEcCtD
Carboprost Tromethamine—Pain—Pravastatin—atherosclerosis	0.00228	0.00402	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00228	0.00402	CcSEcCtD
Carboprost Tromethamine—Asthenia—Lovastatin—atherosclerosis	0.00226	0.00399	CcSEcCtD
Carboprost Tromethamine—Asthenia—Ezetimibe—atherosclerosis	0.00222	0.00392	CcSEcCtD
Carboprost Tromethamine—Nausea—Rosuvastatin—atherosclerosis	0.00221	0.0039	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Simvastatin—atherosclerosis	0.00218	0.00384	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Lovastatin—atherosclerosis	0.00216	0.00381	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Niacin—atherosclerosis	0.00214	0.00378	CcSEcCtD
Carboprost Tromethamine—Asthenia—Simvastatin—atherosclerosis	0.00212	0.00373	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Ezetimibe—atherosclerosis	0.00212	0.00373	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Pravastatin—atherosclerosis	0.00211	0.00372	CcSEcCtD
Carboprost Tromethamine—Dizziness—Lovastatin—atherosclerosis	0.00209	0.00368	CcSEcCtD
Carboprost Tromethamine—Dizziness—Ezetimibe—atherosclerosis	0.00205	0.00361	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Simvastatin—atherosclerosis	0.00202	0.00356	CcSEcCtD
Carboprost Tromethamine—Vomiting—Lovastatin—atherosclerosis	0.00201	0.00354	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Niacin—atherosclerosis	0.002	0.00352	CcSEcCtD
Carboprost Tromethamine—Rash—Lovastatin—atherosclerosis	0.00199	0.00351	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Lovastatin—atherosclerosis	0.00199	0.00351	CcSEcCtD
Carboprost Tromethamine—Headache—Lovastatin—atherosclerosis	0.00198	0.00349	CcSEcCtD
Carboprost Tromethamine—Vomiting—Ezetimibe—atherosclerosis	0.00197	0.00347	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Pravastatin—atherosclerosis	0.00197	0.00347	CcSEcCtD
Carboprost Tromethamine—Dizziness—Simvastatin—atherosclerosis	0.00195	0.00344	CcSEcCtD
Carboprost Tromethamine—Rash—Ezetimibe—atherosclerosis	0.00195	0.00344	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Ezetimibe—atherosclerosis	0.00195	0.00344	CcSEcCtD
Carboprost Tromethamine—Asthenia—Niacin—atherosclerosis	0.00194	0.00343	CcSEcCtD
Carboprost Tromethamine—Headache—Ezetimibe—atherosclerosis	0.00194	0.00342	CcSEcCtD
Carboprost Tromethamine—Asthenia—Pravastatin—atherosclerosis	0.00192	0.00338	CcSEcCtD
Carboprost Tromethamine—Vomiting—Simvastatin—atherosclerosis	0.00188	0.00331	CcSEcCtD
Carboprost Tromethamine—Nausea—Lovastatin—atherosclerosis	0.00187	0.00331	CcSEcCtD
Carboprost Tromethamine—Rash—Simvastatin—atherosclerosis	0.00186	0.00328	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Simvastatin—atherosclerosis	0.00186	0.00328	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Niacin—atherosclerosis	0.00185	0.00327	CcSEcCtD
Carboprost Tromethamine—Headache—Simvastatin—atherosclerosis	0.00185	0.00326	CcSEcCtD
Carboprost Tromethamine—Nausea—Ezetimibe—atherosclerosis	0.00184	0.00324	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Pravastatin—atherosclerosis	0.00183	0.00322	CcSEcCtD
Carboprost Tromethamine—Dizziness—Niacin—atherosclerosis	0.00179	0.00316	CcSEcCtD
Carboprost Tromethamine—Dizziness—Pravastatin—atherosclerosis	0.00177	0.00311	CcSEcCtD
Carboprost Tromethamine—Nausea—Simvastatin—atherosclerosis	0.00175	0.00309	CcSEcCtD
Carboprost Tromethamine—Vomiting—Niacin—atherosclerosis	0.00172	0.00304	CcSEcCtD
Carboprost Tromethamine—Rash—Niacin—atherosclerosis	0.00171	0.00301	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Niacin—atherosclerosis	0.00171	0.00301	CcSEcCtD
Carboprost Tromethamine—Headache—Niacin—atherosclerosis	0.0017	0.00299	CcSEcCtD
Carboprost Tromethamine—Vomiting—Pravastatin—atherosclerosis	0.0017	0.00299	CcSEcCtD
Carboprost Tromethamine—Rash—Pravastatin—atherosclerosis	0.00168	0.00297	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Pravastatin—atherosclerosis	0.00168	0.00296	CcSEcCtD
Carboprost Tromethamine—Headache—Pravastatin—atherosclerosis	0.00167	0.00295	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CNR2—atherosclerosis	0.00163	0.00378	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00162	0.00376	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00162	0.00376	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Niacin—atherosclerosis	0.00161	0.00284	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HRH1—atherosclerosis	0.0016	0.00372	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Pravastatin—atherosclerosis	0.00159	0.0028	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGT—atherosclerosis	0.00153	0.00356	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGT—atherosclerosis	0.0015	0.00349	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRH1—atherosclerosis	0.00149	0.00345	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRH1—atherosclerosis	0.00145	0.00338	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00145	0.00337	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00144	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL3—atherosclerosis	0.00143	0.00332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00142	0.0033	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—F2—atherosclerosis	0.00142	0.00329	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00141	0.00328	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL3—atherosclerosis	0.0014	0.00325	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—F2—atherosclerosis	0.00139	0.00322	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00137	0.00319	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00134	0.00312	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—EDNRA—atherosclerosis	0.00129	0.003	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR2—atherosclerosis	0.00129	0.003	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00127	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR2—atherosclerosis	0.00127	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—EDNRA—atherosclerosis	0.00127	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GHRL—atherosclerosis	0.00126	0.00293	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00124	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GHRL—atherosclerosis	0.00123	0.00286	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00122	0.00284	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00121	0.00282	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.0012	0.00278	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00119	0.00276	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—KNG1—atherosclerosis	0.00111	0.00257	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR1—atherosclerosis	0.0011	0.00255	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—KNG1—atherosclerosis	0.00108	0.00251	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR1—atherosclerosis	0.00108	0.0025	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL4—atherosclerosis	0.00107	0.00249	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—UTS2—atherosclerosis	0.00105	0.00245	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL4—atherosclerosis	0.00105	0.00244	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—UTS2—atherosclerosis	0.00103	0.0024	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00102	0.00236	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CASR—atherosclerosis	0.00101	0.00235	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000994	0.00231	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CASR—atherosclerosis	0.000989	0.0023	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—UTS2—atherosclerosis	0.000957	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR2—atherosclerosis	0.000939	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000938	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—UTS2—atherosclerosis	0.000937	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—EDN1—atherosclerosis	0.000932	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL5—atherosclerosis	0.000925	0.00215	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR2—atherosclerosis	0.000919	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000919	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CX3CR1—atherosclerosis	0.000917	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CASR—atherosclerosis	0.000917	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—EDN1—atherosclerosis	0.000912	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL5—atherosclerosis	0.000905	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CX3CL1—atherosclerosis	0.0009	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000898	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CASR—atherosclerosis	0.000898	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000881	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRH1—atherosclerosis	0.000877	0.00204	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRH1—atherosclerosis	0.000859	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR2—atherosclerosis	0.000853	0.00198	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000836	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR2—atherosclerosis	0.000835	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000819	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGT—atherosclerosis	0.000773	0.0018	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGT—atherosclerosis	0.000757	0.00176	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL3—atherosclerosis	0.000733	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR2—atherosclerosis	0.00073	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—EDNRA—atherosclerosis	0.00073	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL3—atherosclerosis	0.000718	0.00167	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000715	0.00166	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR2—atherosclerosis	0.000715	0.00166	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—F2—atherosclerosis	0.000715	0.00166	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GHRL—atherosclerosis	0.000712	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—F2—atherosclerosis	0.000699	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GHRL—atherosclerosis	0.000697	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOA4—atherosclerosis	0.000688	0.0016	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000686	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOA4—atherosclerosis	0.000674	0.00157	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000672	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EDNRA—atherosclerosis	0.000663	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR2—atherosclerosis	0.000663	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000661	0.00154	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EDNRA—atherosclerosis	0.000649	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR2—atherosclerosis	0.000649	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000647	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GHRL—atherosclerosis	0.000646	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL2—atherosclerosis	0.000637	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL4—atherosclerosis	0.000634	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GHRL—atherosclerosis	0.000633	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—KNG1—atherosclerosis	0.000625	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL2—atherosclerosis	0.000623	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR1—atherosclerosis	0.000621	0.00144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL4—atherosclerosis	0.000621	0.00144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—KNG1—atherosclerosis	0.000612	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000608	0.00141	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOA2—atherosclerosis	0.000593	0.00138	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOA2—atherosclerosis	0.00058	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KNG1—atherosclerosis	0.000567	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—UTS2—atherosclerosis	0.000565	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR1—atherosclerosis	0.000564	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KNG1—atherosclerosis	0.000555	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—UTS2—atherosclerosis	0.000553	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR1—atherosclerosis	0.000552	0.00128	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CX3CR1—atherosclerosis	0.000542	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASR—atherosclerosis	0.000542	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CX3CL1—atherosclerosis	0.000532	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CX3CR1—atherosclerosis	0.000531	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASR—atherosclerosis	0.000531	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—EDN1—atherosclerosis	0.000527	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCL5—atherosclerosis	0.000522	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CX3CL1—atherosclerosis	0.00052	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—EDN1—atherosclerosis	0.000515	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCL5—atherosclerosis	0.000511	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR2—atherosclerosis	0.000504	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—atherosclerosis	0.000504	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MMP3—atherosclerosis	0.000503	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000502	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PRKCG—atherosclerosis	0.000497	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR2—atherosclerosis	0.000493	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—atherosclerosis	0.000493	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MMP3—atherosclerosis	0.000492	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000491	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000486	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EDN1—atherosclerosis	0.000478	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL5—atherosclerosis	0.000474	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EDN1—atherosclerosis	0.000468	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL5—atherosclerosis	0.000464	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PRKCG—atherosclerosis	0.000451	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VWF—atherosclerosis	0.000449	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOC3—atherosclerosis	0.000446	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LDLR—atherosclerosis	0.000444	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PRKCG—atherosclerosis	0.000442	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VWF—atherosclerosis	0.00044	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGT—atherosclerosis	0.000437	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOC3—atherosclerosis	0.000437	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LDLR—atherosclerosis	0.000434	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL3—atherosclerosis	0.000433	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGT—atherosclerosis	0.000428	0.000994	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL3—atherosclerosis	0.000424	0.000985	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NCF1—atherosclerosis	0.000415	0.000964	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NCF1—atherosclerosis	0.000406	0.000944	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—F2—atherosclerosis	0.000404	0.000938	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGT—atherosclerosis	0.000397	0.000922	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—F2—atherosclerosis	0.000395	0.000918	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR2—atherosclerosis	0.000392	0.00091	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EDNRA—atherosclerosis	0.000392	0.00091	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CYBA—atherosclerosis	0.00039	0.000906	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGT—atherosclerosis	0.000388	0.000903	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000386	0.000898	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR2—atherosclerosis	0.000384	0.000891	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EDNRA—atherosclerosis	0.000384	0.000891	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GHRL—atherosclerosis	0.000382	0.000887	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CYBA—atherosclerosis	0.000382	0.000887	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PARP1—atherosclerosis	0.000382	0.000887	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PLAT—atherosclerosis	0.000382	0.000887	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000378	0.000879	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PLAT—atherosclerosis	0.000374	0.000868	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GHRL—atherosclerosis	0.000374	0.000868	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PARP1—atherosclerosis	0.000374	0.000868	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—F2—atherosclerosis	0.000367	0.000852	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—F2—atherosclerosis	0.000359	0.000834	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CG—atherosclerosis	0.000351	0.000815	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000344	0.000798	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KNG1—atherosclerosis	0.000335	0.000779	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR1—atherosclerosis	0.000333	0.000774	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KNG1—atherosclerosis	0.000328	0.000762	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—atherosclerosis	0.000327	0.000759	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR1—atherosclerosis	0.000326	0.000758	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PLG—atherosclerosis	0.000325	0.000754	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—atherosclerosis	0.00032	0.000743	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PLG—atherosclerosis	0.000318	0.000738	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SOCS3—atherosclerosis	0.000307	0.000714	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SOCS3—atherosclerosis	0.000301	0.000699	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP3—atherosclerosis	0.000297	0.00069	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—atherosclerosis	0.000296	0.000687	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP3—atherosclerosis	0.000291	0.000675	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—atherosclerosis	0.000289	0.000672	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOB—atherosclerosis	0.000287	0.000667	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—atherosclerosis	0.000285	0.000661	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EDN1—atherosclerosis	0.000282	0.000656	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOB—atherosclerosis	0.000281	0.000653	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL5—atherosclerosis	0.00028	0.000651	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000279	0.000647	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EDN1—atherosclerosis	0.000276	0.000642	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL5—atherosclerosis	0.000274	0.000637	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LPL—atherosclerosis	0.000274	0.000637	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LPL—atherosclerosis	0.000268	0.000623	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PRKCG—atherosclerosis	0.000266	0.000619	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PRKCG—atherosclerosis	0.000261	0.000606	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—atherosclerosis	0.00026	0.000603	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—atherosclerosis	0.000258	0.0006	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—atherosclerosis	0.000254	0.00059	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—atherosclerosis	0.000253	0.000588	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDGFB—atherosclerosis	0.00024	0.000558	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDGFB—atherosclerosis	0.000235	0.000546	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGT—atherosclerosis	0.000234	0.000545	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOE—atherosclerosis	0.00023	0.000534	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LEP—atherosclerosis	0.00023	0.000534	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGT—atherosclerosis	0.000229	0.000533	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CAV1—atherosclerosis	0.000228	0.000529	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOA1—atherosclerosis	0.000227	0.000528	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LEP—atherosclerosis	0.000225	0.000522	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOE—atherosclerosis	0.000225	0.000522	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CAV1—atherosclerosis	0.000223	0.000518	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOA1—atherosclerosis	0.000222	0.000516	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ESR1—atherosclerosis	0.000219	0.00051	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—F2—atherosclerosis	0.000217	0.000503	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ESR1—atherosclerosis	0.000215	0.000499	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—F2—atherosclerosis	0.000212	0.000493	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—atherosclerosis	0.000207	0.000482	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—atherosclerosis	0.000203	0.000471	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—atherosclerosis	0.000199	0.000461	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INS—atherosclerosis	0.000196	0.000456	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—atherosclerosis	0.000194	0.000451	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL2—atherosclerosis	0.000193	0.000449	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INS—atherosclerosis	0.000192	0.000446	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1—atherosclerosis	0.00019	0.000441	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL2—atherosclerosis	0.000189	0.000439	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1—atherosclerosis	0.000186	0.000432	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—atherosclerosis	0.00018	0.000419	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—atherosclerosis	0.000176	0.00041	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOS3—atherosclerosis	0.000172	0.0004	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOS3—atherosclerosis	0.000168	0.000391	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—atherosclerosis	0.000153	0.000355	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—atherosclerosis	0.000149	0.000347	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—atherosclerosis	0.000147	0.000343	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—atherosclerosis	0.000145	0.000337	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—atherosclerosis	0.000144	0.000335	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—atherosclerosis	0.000142	0.00033	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—atherosclerosis	0.000138	0.000321	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NFKB1—atherosclerosis	0.000137	0.000317	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—atherosclerosis	0.000135	0.000314	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK8—atherosclerosis	0.000134	0.000312	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—atherosclerosis	0.000134	0.000311	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NFKB1—atherosclerosis	0.000134	0.000311	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK8—atherosclerosis	0.000131	0.000305	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—atherosclerosis	0.000131	0.000305	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—atherosclerosis	0.000124	0.000288	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—atherosclerosis	0.000123	0.000285	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—atherosclerosis	0.000121	0.000282	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—atherosclerosis	0.00012	0.000279	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—atherosclerosis	0.000117	0.000272	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—atherosclerosis	0.000115	0.000267	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—atherosclerosis	0.000114	0.000264	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—atherosclerosis	0.000111	0.000259	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—atherosclerosis	8.58e-05	0.000199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—atherosclerosis	8.39e-05	0.000195	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—atherosclerosis	7.91e-05	0.000184	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—atherosclerosis	7.74e-05	0.00018	CbGpPWpGaD
